WO2001074993A3 - Nouveau polypeptide, proteine humaine a doigt de zinc 17, et polynucleotide codant pour ce polypeptide - Google Patents
Nouveau polypeptide, proteine humaine a doigt de zinc 17, et polynucleotide codant pour ce polypeptide Download PDFInfo
- Publication number
- WO2001074993A3 WO2001074993A3 PCT/CN2001/000184 CN0100184W WO0174993A3 WO 2001074993 A3 WO2001074993 A3 WO 2001074993A3 CN 0100184 W CN0100184 W CN 0100184W WO 0174993 A3 WO0174993 A3 WO 0174993A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptide
- polynucleotide encoding
- zinc finger
- finger protein
- human zinc
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 101000818752 Homo sapiens Zinc finger protein 17 Proteins 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 101710160450 Zinc finger protein 17 Proteins 0.000 abstract 1
- 102100021376 Zinc finger protein 17 Human genes 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
L'invention concerne un nouveau polypeptide, une protéine humaine à doigt de zinc 17, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hémopathie, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la protéine humaine à doigt de zinc 17.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU44037/01A AU4403701A (en) | 2000-03-10 | 2001-02-26 | A novel polypeptide, human zinc-finger protein 17 and the polynucleotide encoding the polypeptide |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00111974A CN1313308A (zh) | 2000-03-10 | 2000-03-10 | 一种新的多肽——人锌指蛋白17和编码这种多肽的多核苷酸 |
| CN00111974.5 | 2000-03-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001074993A2 WO2001074993A2 (fr) | 2001-10-11 |
| WO2001074993A3 true WO2001074993A3 (fr) | 2002-11-28 |
Family
ID=4581870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2001/000184 WO2001074993A2 (fr) | 2000-03-10 | 2001-02-26 | Nouveau polypeptide, proteine humaine a doigt de zinc 17, et polynucleotide codant pour ce polypeptide |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1313308A (fr) |
| AU (1) | AU4403701A (fr) |
| WO (1) | WO2001074993A2 (fr) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996011267A1 (fr) * | 1994-10-07 | 1996-04-18 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Adn et proteine a doigts de zinc et leur utilisation |
| WO1999062952A1 (fr) * | 1998-06-04 | 1999-12-09 | Shanghai Second Medical University | Gene de proteine humaine a doigts de zinc (bmzf2) |
| WO1999062951A1 (fr) * | 1998-06-04 | 1999-12-09 | Shanghai Second Medical University | Gene humain de proteine a doigts de zinc (bmzf3) |
-
2000
- 2000-03-10 CN CN00111974A patent/CN1313308A/zh active Pending
-
2001
- 2001-02-26 AU AU44037/01A patent/AU4403701A/en not_active Abandoned
- 2001-02-26 WO PCT/CN2001/000184 patent/WO2001074993A2/fr active Application Filing
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996011267A1 (fr) * | 1994-10-07 | 1996-04-18 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Adn et proteine a doigts de zinc et leur utilisation |
| WO1999062952A1 (fr) * | 1998-06-04 | 1999-12-09 | Shanghai Second Medical University | Gene de proteine humaine a doigts de zinc (bmzf2) |
| WO1999062951A1 (fr) * | 1998-06-04 | 1999-12-09 | Shanghai Second Medical University | Gene humain de proteine a doigts de zinc (bmzf3) |
Also Published As
| Publication number | Publication date |
|---|---|
| AU4403701A (en) | 2001-10-15 |
| WO2001074993A2 (fr) | 2001-10-11 |
| CN1313308A (zh) | 2001-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001074993A3 (fr) | Nouveau polypeptide, proteine humaine a doigt de zinc 17, et polynucleotide codant pour ce polypeptide | |
| WO2001079423A3 (fr) | Nouveau polypeptide, proteine humaine bcr 10, et polynucleotide codant pour ce polypeptide | |
| WO2001083677A3 (fr) | Nouveau polypeptide, proteine humaine fh2-13 de deformation des ailes de coq, et polynucleotide codant pour ce polypeptide | |
| WO2001079425A3 (fr) | Nouveau polypeptide, canal ionique humain 10 pour le chlore, et polynucleotide codant pour ce polypeptide | |
| WO2001075041A3 (fr) | Nouveau polypeptide, proteine humaine associee a l'epilepsie 11, et polynucleotide codant pour ce polypeptide | |
| WO2001075030A3 (fr) | Nouveau polypeptide, tyrosinase humaine 11, et polynucleotide codant pour ce polypeptide | |
| WO2002000822A3 (fr) | Nouveau polypeptide, sous-unite humaine 2 $g(b) 16.5 du facteur d'initiation necessaire a la synthese proteique, et polynucleotide codant ce polypeptide | |
| WO2001079429A3 (fr) | Nouveau polypeptide, facteur humain d'echange guanine nucleotide 10, et polynucleotide codant pour ce polypeptide | |
| WO2001075055A3 (fr) | Nouveau polypeptide, quinine reductase humaine 9, et polynucleotide codant pour ce polypeptide | |
| WO2001075045A3 (fr) | Nouveau polypeptide, chaine legere de clathrine humaine 17, et polynucleotide codant pour ce polypeptide | |
| WO2001045729A8 (fr) | Nouveau polypeptide, phosphoproteine ribosomale humaine 16, et polynucleotide codant pour ce polypeptide | |
| WO2001079436A3 (fr) | Nouveau polypeptide, facteur humain de transcription de la differentiation cellulaire 10, et polynucleotide codant pour ce polypeptide | |
| WO2001075019A3 (fr) | Nouveau polypeptide, proteine humaine de mutation 11 de l'ataxie-telangiectasie, et polynucleotide codant pour ce polypeptide | |
| WO2001079430A3 (fr) | Nouveau polypeptide, serine protease humaine 9, et polynucleotide codant pour ce polypeptide | |
| WO2002000821A3 (fr) | Nouveau polypeptide, proteine humaine plp 39, et polynucleotide codant ce polypeptide | |
| WO2001075048A3 (fr) | Nouveau polypeptide, proteine ribosomale humaine s11 23, et polynucleotide codant pour ce polypeptide | |
| WO2001075036A3 (fr) | Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide | |
| WO2001075038A3 (fr) | Nouveau polypeptide, serine hydrolase humaine 9 atp-dependante, et polynucleotide codant pour ce polypeptide | |
| WO2001075044A3 (fr) | Nouveau polypeptide, proteine ribosomale humaine s18-18, et polynucleotide codant pour ce polypeptide | |
| WO2001083758A3 (fr) | Nouveau polypeptide, dihydroorotase humaine 8, et polynucleotide codant pour ce polypeptide | |
| WO2001075059A3 (fr) | Nouveau polypeptide, proteine humaine 11 de regulation de gtp, et polynucleotide codant pour ce polypeptide | |
| WO2002008427A1 (fr) | Nouveau polypeptide, pompe sodium-potassium humaine 9,57, et polynucleotide codant ce polypeptide | |
| WO2001075016A3 (fr) | Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide | |
| WO2002000828A3 (fr) | Nouveau polypeptide, proteine a doigt de zinc 34, et polynucleotide codant ce polypeptide | |
| WO2001083682A3 (fr) | Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| NENP | Non-entry into the national phase |
Ref country code: JP |